OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A partnership with the proteasome; the destructive nature of GSK3
Holly Robertson, John D. Hayes, Calum Sutherland
Biochemical Pharmacology (2017) Vol. 147, pp. 77-92
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Nrf2: Molecular and epigenetic regulation during aging
Alejandro Silva‐Palacios, M. Ostolga-Chavarría, Cecilia Zazueta, et al.
Ageing Research Reviews (2018) Vol. 47, pp. 31-40
Closed Access | Times Cited: 162

Nrf2 for cardiac protection: pharmacological options against oxidative stress
Qin M. Chen
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 9, pp. 729-744
Open Access | Times Cited: 103

GSK3: A Kinase Balancing Promotion and Resolution of Inflammation
Leonie Hoffmeister, Mareike Diekmann, Korbinian Brand, et al.
Cells (2020) Vol. 9, Iss. 4, pp. 820-820
Open Access | Times Cited: 108

Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target?
Luca Braglia, Manuela Zavatti, Marco Vinceti, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2020) Vol. 1867, Iss. 9, pp. 118731-118731
Open Access | Times Cited: 81

Nrf2: The Master and Captain of Beta Cell Fate
Sharon Baumel-Alterzon, Liora S. Katz, Gabriel Brill, et al.
Trends in Endocrinology and Metabolism (2020) Vol. 32, Iss. 1, pp. 7-19
Open Access | Times Cited: 79

NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases
Ángel Cores, Marta Piquero, Mercedes Villacampa, et al.
Biomolecules (2020) Vol. 10, Iss. 6, pp. 904-904
Open Access | Times Cited: 72

Triple-negative breast cancer: understanding Wnt signaling in drug resistance
Parnaz Merikhian, Mohammad Reza Eisavand, Leila Farahmand
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 72

A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis
Catherine Blaha, Gopalakrishnan Ramakrishnan, Sang‐Min Jeon, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 52

Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2
Boushra Bathish, Holly Robertson, John Dillon, et al.
Free Radical Biology and Medicine (2022) Vol. 188, pp. 221-261
Open Access | Times Cited: 50

DNA damage-induced transcription stress triggers the genome-wide degradation of promoter-bound Pol II
Barbara Steurer, Roel C. Janssens, Marit E. Geijer, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 42

GSK-3β: An exuberating neuroinflammatory mediator in Parkinson's disease
Sabiya Samim Khan, Sushmita Janrao, Saurabh Srivastava, et al.
Biochemical Pharmacology (2023) Vol. 210, pp. 115496-115496
Open Access | Times Cited: 40

Safety screening in early drug discovery: An optimized assay panel
Stefanie Bendels, Caterina Bissantz, Bernhard Fasching, et al.
Journal of Pharmacological and Toxicological Methods (2019) Vol. 99, pp. 106609-106609
Closed Access | Times Cited: 70

New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
Geoffroy Danieau, Sarah Morice, Françoise Rédiní, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 15, pp. 3751-3751
Open Access | Times Cited: 68

Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer
Camilla Evangelisti, Francesca Chiarini, Francesca Paganelli, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2019) Vol. 1867, Iss. 4, pp. 118635-118635
Open Access | Times Cited: 60

Inhibition of glycogen synthase kinase-3 enhances NRF2 protein stability, nuclear localisation and target gene transcription in pancreatic beta cells
Chinmai Patibandla, Lidy van Aalten, Albena T. Dinkova‐Kostova, et al.
Redox Biology (2024) Vol. 71, pp. 103117-103117
Open Access | Times Cited: 7

Gephyrin: a key regulatory protein of inhibitory synapses and beyond
Femke Groeneweg, Christa Trattnig, Jochen Kuhse, et al.
Histochemistry and Cell Biology (2018) Vol. 150, Iss. 5, pp. 489-508
Closed Access | Times Cited: 57

FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation–Induced Mitochondrial Oxidative Stress
Roberto Ronca, Gaia C. Ghedini, Federica Maccarinelli, et al.
Cancer Research (2020) Vol. 80, Iss. 11, pp. 2340-2354
Open Access | Times Cited: 44

CRYPTOCHROMES confer robustness, not rhythmicity, to circadian timekeeping
Marrit Putker, David Wong, Estere Seinkmane, et al.
The EMBO Journal (2021) Vol. 40, Iss. 7
Open Access | Times Cited: 34

Role and Therapeutic Implication of Wnt Signalling Pathway in Cancer
Aga Syed Sameer, Saniya Nissar, Mujeeb Zafar Banday
(2025), pp. 205-233
Closed Access

The role of glycogen synthase kinase 3 beta in multiple sclerosis
Tayebeh Noori, Ahmad Reza Dehpour, Antoni Sureda, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110874-110874
Open Access | Times Cited: 37

DNA Damage Promotes TMPRSS2-ERG Oncoprotein Destruction and Prostate Cancer Suppression via Signaling Converged by GSK3β and WEE1
Zhe Hong, Wei Zhang, Donglin Ding, et al.
Molecular Cell (2020) Vol. 79, Iss. 6, pp. 1008-1023.e4
Open Access | Times Cited: 33

GSK-3: a multifaceted player in acute leukemias
Alberto M. Martelli, Camilla Evangelisti, Francesca Paganelli, et al.
Leukemia (2021) Vol. 35, Iss. 7, pp. 1829-1842
Closed Access | Times Cited: 30

The time-resolved genomic impact of Wnt/β-catenin signaling
Pierfrancesco Pagella, Simon Söderholm, Anna Nordin, et al.
Cell Systems (2023) Vol. 14, Iss. 7, pp. 563-581.e7
Open Access | Times Cited: 12

Nrf2 in TIME: The Emerging Role of Nuclear Factor Erythroid 2-Related Factor 2 in the Tumor Immune Microenvironment
Jialin Feng, Oliver J. Read, Albena T. Dinkova‐Kostova
Molecules and Cells (2023) Vol. 46, Iss. 3, pp. 142-152
Open Access | Times Cited: 11

Page 1 - Next Page

Scroll to top